Smith Asset Management’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$675K Sell
15,287
-892
-6% -$39.5K 0.55% 46
2026
Q2
$695K Sell
16,179
-350
-2% -$13.9K 0.55% 46
2026
Q1
$637K Buy
16,529
+3,644
+28% +$150K 0.55% 46
2025
Q4
$530K Buy
12,885
+2,301
+22% +$90.9K 0.44% 50
2025
Q3
$394K Buy
10,584
+918
+9% +$33.4K 0.34% 54
2025
Q2
$352K Buy
9,666
+3,136
+48% +$114K 0.3% 58
2025
Q1
$252K Buy
+6,530
New +$259K 0.24% 55

Other funds holding BME

Smith Asset Management's BME Position: Q3 2026 in Review

Smith Asset Management reduced its BlackRock Health Sciences Trust (BME) stake by 5.5% in Q3 2026, selling an estimated $39.5K and leaving 15,287 shares worth $675K. The position accounts for 0.55% of the portfolio, ranked #46.

Smith Asset Management first reported a position in BME in Q1 2025 and has held it in 7 quarters since. The position peaked at $695K in Q2 2026. 23 funds tracked by Wall St. Rank hold BME as of Q3 2026.

  • Smith Asset Management held 15,287 shares of BlackRock Health Sciences Trust worth $675K as of Q3 2026.
  • Smith Asset Management sold 892 BlackRock Health Sciences Trust shares in Q3 2026, an estimated $39.5K.
  • BlackRock Health Sciences Trust made up 0.55% of Smith Asset Management's portfolio in Q3 2026, its #46 holding.
  • Smith Asset Management first reported a position in BlackRock Health Sciences Trust in Q1 2025 and has held it in 7 quarters since.
  • Smith Asset Management's BlackRock Health Sciences Trust position peaked at $695K in Q2 2026.
  • 23 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q3 2026.

Based on Smith Asset Management's 13F filing for Q3 2026, filed 16 Oct 2026.